THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS

Session Chair:

Andrew Bradbury, M.D., Ph.D., Chief Scientific Officer, Specifica

Session Chair:

James Larrick, M.D., Ph.D., Managing Director and Chief Medical Officer, Panorama Research Institute and Velocity Pharmaceutical Development

Session Chairs:

Janine Schuurman, Ph.D., Vice President, Research, Genmab, The Netherlands

James A. Ernst, Ph.D., Senior Director, Head of Development Sciences, Xencor

Session Chair:

Sally Ward, Ph.D., Professor, University of Southampton and Texas A&M University Health Science Center 

Session Chair:

Paul J. Carter, Ph.D., Senior Director and Senior Staff Scientist, Antibody Engineering, Genentech, Inc.

Session Chairs:

Paul W.H.I. Parren, Ph.D., Professor, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center and EVP and Head of R&D, Lava Therapeutics, The Netherlands

Katherine Harris, Ph.D., Senior Director of Discovery at Teneobio

Session Chair:

Andrew Ward, Ph.D., Professor, Department of Integrative Structural and Computational Biology, The Scripps Research Institute

Session Chair:

Dennis R. Burton, Ph.D., Professor, Department of Immunology and Microbiology, The Scripps Research Institute

Session Chair:

Andreas Plückthun, Ph.D., Professor and Director, Department of Biochemistry, University of Zürich, Switzerland

Session Chairs:

Jennifer Cochran, Ph.D., Professor and Department Chair of Bioengineering, Stanford University

Kerry A. Chester, Ph.D., Professor of Molecular Medicine, UCL Cancer Institute, University College London, United Kingdom

Session Chairs:

Jamie K. Scott, M.D., Ph.D., Professor Emeritus, Department of Molecular Biology & Biochemistry and Faculty of Health Sciences, Simon Fraser University, Canada

Jean-Philippe Bürckert, Ph.D., Director of Computational Immunology, Distributed Bio

Juan Carlos Almagro, Ph.D., Founder and Director, GlobalBio

Session Chairs:

Anne Messer, Ph.D., Professor of Biomedical Sciences, University at Albany and Principal Investigator, Neural Stem Cell Institute, Regenerative Research Foundation

Gregory Adams, Ph.D., Chief Scientific Officer, Elucida Oncology

Mitchell Ho, Ph.D., Senior Investigator, Laboratory of Molecular Biology, NIH NCI

Session Chair:

Falk Nimmerjahn, Ph.D., Professor, Division of Genetics, University of Erlangen-Nuremberg, Germany

Session Chair:

K. Dane Wittrup, Ph.D., C.P. Dubbs Professor of Chemical Engineering and Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Session Chair:

Stephen Parmley, Ph.D., Vice President, Molecular Biology & Protein Sciences, AnaptysBio

Session Chair:

Sai Reddy, Ph.D., Associate Professor, Department of Biosystems Science and Engineering, ETH Zurich/Swiss Federal Institute of Technology, Switzerland